Vaccination
Business Model:
Revenue: $0
Employees: 1-10
Address:
City:
State:
Zip:
Country:
Potent, Fast and Safe Cancer Vaccination. Impfkraft develops potent T cell vaccines based on living Orf-virus (parapoxvirus) vectors with an excellent safety profile. Our vectors comprise transgenes in a modular design, which are cancer or even patient specific. The employed transgenes code for a combination of cytokines, activation signals, and checkpoint antibodies. Additionally, our system allows the combination of different antigen formats and different modes of antigen presentation. Due to our innovative selection system, these highly potent, flexible and safe cancer vaccines will be available only a few weeks after mail order.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|